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A B S T R A C T
LSD is an ambiguous substance, said to mimic psychosis and to improve mental health in people suﬀering from
anxiety and depression. Little is known about the neuronal correlates of altered states of consciousness induced
by this substance. Limited previous studies indicated profound changes in functional connectivity of resting state
networks after the administration of LSD. The current investigation attempts to replicate and extend those
ﬁndings in an independent sample. In a double-blind, randomized, cross-over study, 100 μg LSD and placebo
were orally administered to 20 healthy participants. Resting state brain activity was assessed by functional
magnetic resonance imaging. Within-network and between-network connectivity measures of ten established
resting state networks were compared between drug conditions. Complementary analysis were conducted using
resting state networks as sources in seed-to-voxel analyses. Acute LSD administration signiﬁcantly decreased
functional connectivity within visual, sensorimotor and auditory networks and the default mode network. While
between-network connectivity was widely increased and all investigated networks were aﬀected to some extent,
seed-to-voxel analyses consistently indicated increased connectivity between networks and subcortical (tha-
lamus, striatum) and cortical (precuneus, anterior cingulate cortex) hub structures. These latter observations are
consistent with ﬁndings on the importance of hubs in psychopathological states, especially in psychosis, and
could underlay therapeutic eﬀects of hallucinogens as proposed by a recent model.
1. Introduction
In recent years, there has been increasing interest in research on
hallucinogenic drugs such as psilocybin, DMT (N,N-dimethyl-
tryptamine), and LSD (lysergic acid diethylamide) (Nichols, 2016;
Liechti, 2017). Several eﬀects induced by hallucinogenic drugs re-
semble symptoms observed in schizophrenia (Gouzoulis-Mayfrank
et al., 1998) and these drugs are therefore thought to serve as models of
psychosis and might provide further insight into the pathophysiology of
this mental disease (Geyer and Vollenweider, 2008). It is also assumed,
that hallucinogens can improve mental health in people suﬀering from
anxiety and depression (Nichols, 2016; Nichols et al., 2016). Compared
with conventional psychopharmacological treatments, this approach is
promising because long-lasting improvements resulting from one or a
few administrations have been reported (Nichols et al., 2016). How-
ever, little is known about the neural correlates underlying these ef-
fects. Functional magnetic resonance imaging (fMRI) can be used to
assess hemodynamic signatures as an indirect measure for neuronal
activity. Two recent articles (Carhart-Harris et al., 2016b; Tagliazucchi
et al., 2016) on the neuronal eﬀects of LSD reported widespread
alterations in functional connectivity (FC), a measure used to char-
acterize functional integration by assessing the statistical dependency
between spatially remote brain regions (Friston, 2011). It was found
that LSD acutely decreased coactivation within several resting state
networks (RSNs), but increased FC between networks (Carhart-Harris
et al., 2016b). The same group also reported increases in between net-
work FC after the administration of the related substance psilocybin in
another sample (Carhart-Harris et al., 2013; Roseman et al., 2014).
However, those studies were limited by small sample sizes and sig-
niﬁcant diﬀerences in head motion between conditions, which could
have biased the results (Power et al., 2014). Apart from one report on
DMT, which conﬁrmed decreased FC within the default mode network
(DMN) (Palhano-Fontes et al., 2015), no attempt has been made to
replicate these ﬁndings in an independent sample. Moreover, the sig-
niﬁcance of these ﬁndings with regard to subjective drug eﬀects is
largely unknown (Carhart-Harris et al., 2016b).
In this placebo-controlled study, we investigated the eﬀect of 100 μg
LSD on RSN FC in 20 healthy subjects using fMRI. Based on the iden-
tiﬁcation of ten well established RSNs (Smith et al., 2009) and fol-
lowing the approaches of studies described above (Carhart-Harris et al.,
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2013; Roseman et al., 2014; Carhart-Harris et al., 2016b), the eﬀects of
LSD on FC within and between those networks were assessed in an
attempt to replicate previous ﬁndings (Carhart-Harris et al., 2016b;
Carhart-Harris et al., 2013; Roseman et al., 2014). RSNs were identiﬁed
using independent component analysis (ICA), a widely used, data-
driven method to identify spatially distributed signal components in
fMRI data (Beckmann et al., 2009). With this approach, coherent RSNs
can be identiﬁed and then further analyzed. RSNs can be subdivided
into the default mode network (DMN) and other RSNs. The DMN is
particularly activated during rest and is thought to be involved in
functions such as self-referential thinking (Buckner et al., 2008; Raichle
et al., 2001). On the contrary, other RSNs observed during rest closely
resemble networks involved in demands across diﬀerent tasks (Smith
et al., 2009).
As the data on associations between the described FC measures and
subjective drug eﬀects are limited, we also conducted an exploratory
correlation analysis. Additionally, we tested the only pre-described
associations between decreased FC within the DMN and the subjective
experience of “ego dissolution” (Carhart-Harris et al., 2016b). Fur-
thermore, seed-to-voxel analyses were performed to characterize
changes in the connectivity of RSNs to other regions on a whole-brain
level in more detail – concentrating on changes in FC between RSNs and
hub structures. Hubs are thought to serve integration and large-scale
interactions (van den Heuvel and Sporns, 2013; Bell and Shine, 2016)
and have been implicated as critical structures in various mental dis-
eases, including psychosis (Crossley et al., 2014). These structures are
therefore likely to be involved in hallucinogen-induced alterations in
network FC.
2. Materials and methods
This study was a randomized, placebo-controlled, double-blind,
cross-over trial. Each participant received 100 μg LSD and placebo in a
cross-over manner. The washout period between sessions was at least
seven days. Functional MRI data was acquired for each condition, re-
sulting in two data sets (active drug and placebo) for each participant
(repeated measures design). Conditions were compared using paired t-
tests. The study was approved by the Ethics Committee for Northwest/
Central Switzerland (EKNZ) and by the Federal Oﬃce of Public Health.
All subjects provided written consent prior to participating and re-
ceived monetary compensation. This study was registered at
clinicaltrials.gov prior to study start (NCT02308969).
2.1. Subjects
Participants were recruited by advertisement and word of mouth.
All participants were screened by general medical examination and
psychiatric interview to assess the following exclusion criteria: age <
25 or>65 years, personal or ﬁrst degree relative with an axis I major
psychiatric disorder, history of drug dependence, cardiac or neurolo-
gical disorders, use of any regular medication pregnancy, nursing, hy-
pertension (> 140/90mmHg) or hypotension (SBP < 85mmHg),
smoking> 10 cigarettes/day, use of illicit drugs (except tetra-
hydrocannabinol) > 10 times or any time within the previous two
months (as assessed by history and urine tests). Twenty healthy subjects
out of initially 24 participants were included (10 male, 10 female; mean
age 32 ± 11 years; range: 25–60 years, all but one with university
education and all right-handed). Data sets from four subjects were ex-
cluded from analysis due to movement during the fMRI scan (see
below). Only two participants had used a hallucinogenic drug before,
both on only a single occasion. For data on lifetime drug use of the 20
included subjects see Supplemental Table 1.
2.2. Assessments of plasma levels and subjective drug eﬀects
Subjective eﬀects were assessed three hours after administration of
placebo or LSD (directly after the MRI scan), using the 5 dimensions of
altered states of consciousness (5D-ASC) scale (Dittrich, 1998). This
well validated questionnaire (Studerus et al., 2010) was designed to
measure altered states of consciousness via visual-analog scales. Venous
blood samples were collected in lithium heparin tubes two and three
hours after administration, centrifuged and stored at −20 °C. Plasma
LSD concentrations were measured using a validated tandem mass
spectrometry method (Dolder et al., 2017a).
2.3. Assessment of blood pressure, heart rate, and body temperature
Blood pressure, heart rate, and body temperature were assessed two
and three hours after drug administration. Blood pressure and heart
rate were measured twice at both time points. The average of both
measurements was used for further analysis.
2.4. Image acquisition
Images were acquired using a 3 Tesla MRI system (Magnetom
Prisma, Siemens Healthcare, Erlangen, Germany) with a 20-channel
phased array radio frequency head coil. Anatomical images were ac-
quired using a T1-weighted magnetization prepared rapid acquisition
gradient (MPRAGE) sequence (ﬁeld of view: 256×256mm2; resolu-
tion: 1× 1×1mm3; repetition time: 2000ms; echo time: 3.37ms; ﬂip
angle: 8°; bandwidth: 200 Hz/pixel). This was followed by an inter-
leaved T2*-weighted echo planar imaging resting state sequence. The
following parameters were used: 35 axial slices with a slice thickness of
3.5 mm, a 0.5 mm inter-slice gap, a ﬁeld-of-view of 224× 224 cm2, and
a resolution of 3.5× 3.5× 3.5mm3. The repetition time was 1.8 s,
echo time 28ms, ﬂip angle 82°, and bandwidth 2442 Hz/pixel. During
the scan, participants were instructed to close their eyes and remain
awake. Three hundred volumes were acquired. This resting state scan
was followed by other sequences not relevant for this publication. Total
acquisition time was approximately 50min. Three hundred volumes
were acquired. Subjects with head motion of> 2mm translation
or> 2° rotation were excluded (n=4), resulting in a sample of 20
subjects. No signiﬁcant diﬀerences in head motion were present be-
tween conditions (see Supplementary for more details).
2.5. Preprocessing
Preprocessing was performed using FEAT (FMRI Expert Analysis
Tool) Version 6.00 (part of FSL, www.fmrib.ox.ac.uk/fsl) and SPM12
(http://www.ﬁl.ion.ucl.ac.uk/spm/). Five dummy scans were excluded
and the remaining volumes were quality checked for head motion and
image artifacts. Preprocessing for all volumes included brain extraction,
realignment to the ﬁrst volume, slice time correction, co-registration to
the T1-weighted structural volume, segmentation, normalization into a
standard stereotactic space (Montreal Neurological Institute) and
smoothing with a 5mm full width at half maximum Gaussian kernel.
Preprocessing for the ICA analysis included masking of non-brain
voxels, highpass temporal ﬁltering (0.01 Hz cut-oﬀ), voxel-wise de-
meaning of the data and normalization of the voxel-wise variance. Data
were whitened and projected into a 20-dimensional subspace using
Principal Component Analysis. Preprocessing of between-network
connectivity and seed-to-voxel analysis included scrubbing (global
signal threshold of z > 3, composite subject motion threshold of>
0.5mm) using ART as implemented in CONN and linear regression of
the six motion parameters and the eﬀects of each condition. Five
principal components were extracted from white matter and cere-
brospinal ﬂuid signals (using individual tissue masks obtained from the
T1-weighted structural images) and removed using CompCor (Behzadi
et al., 2007). These components are thought to reﬂect noise (especially
motion and physiological ﬂuctuations) and are therefore removed from
the time series. The resulting functional images were band-pass ﬁltered
(0.008 < f < 0.09 Hz).
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2.6. Independent component analysis
ICA was performed using Probabilistic Independent Component
Analysis as implemented in MELODIC (Multivariate Exploratory Linear
Decomposition into Independent Components) Version 3.14 (part of
FSL, www.fmrib.ox.ac.uk/fsl). This study was restricted to 20 compo-
nents, in order to allow direct comparison with the templates used by
Smith et al. (2009) and previous studies using LSD (Carhart-Harris
et al., 2016b) and psilocybin (Carhart-Harris et al., 2013). The resulting
20 components were visually inspected and components which largely
reﬂected artifacts (8 components) were removed before further analysis
using previously described procedures (Kelly Jr. et al., 2010). The re-
maining 12 components were matched with the ten primary resting
state reference networks via visual inspection and cross-correlation, as
described by Smith et al. (2009). These 10 networks identiﬁed in our
data set were then used for all further analyses.
2.7. Within-network connectivity
Subject-speciﬁc versions of the 10 RSNs in our data set were gen-
erated using dual regression (Beckmann et al., 2009). Diﬀerences be-
tween the LSD and the placebo condition in each component were as-
sessed by a permutation test using Randomise in FSL (paired two-tailed
t-test, 5000 permutations). Clusters were formed using threshold-free
cluster enhancement. To account for testing 10 networks, the initial
threshold of p < 0.05 (FWE) was adjusted (Bonferroni correction),
resulting in a threshold of p < 0.005 (FWE).
2.8. Between-network connectivity and seed-to-voxel analysis
Analysis of FC between RSNs and seed-to-voxel analysis were per-
formed using the CONN functional connectivity toolbox 17a (http://
www.nitrc.org/projects/conn) (Whitﬁeld-Gabrieli and Nieto-Castanon,
2012). Unthresholded maps of RSNs obtained from ICA analysis were
imported as ROIs and the weighted sums of the time series were ex-
tracted. For analysis of FC between networks, time courses between all
ten RSNs were compared for both conditions using bivariate correla-
tion. The resulting correlation coeﬃcients were compared between
placebo and drug conditions, using paired t-tests (two tailed). Results
were corrected for multiple comparisons (10× 10 networks) using the
false discovery rate (FDR). Signiﬁcance for FDR was assumed at
p < 0.05. For seed-to-voxel analysis, the same ROIs were used. Time
courses of each RSN were correlated with time courses of each voxel
throughout the brain. Diﬀerences between placebo and drug condition
were assessed using paired t-tests (two tailed). Results for FDR were
considered signiﬁcant at a cluster threshold of p < 0.005 (two tailed)
on the basis of a cluster-forming threshold of p < 0.001.
2.9. Relationship with subjective drug eﬀects and plasma levels
Associations between subjective drug eﬀects and alterations of
within-network FC were tested in an exploratory correlations analysis.
Individual parameter estimates (PE) obtained from within-network
connectivity analysis (ΔPE=mean PELSD−mean PEPlacebo) were ex-
tracted from signiﬁcantly altered clusters within RSNs (p < 0.005,
FWE, threshold-free cluster enhancement) and then correlated
(Pearson's r) with subjective ratings in the 5D-ASC total scores and in all
ﬁve major dimensions of the 5D-ASC. We further tested the association
between decreased FC within the DMN and subjective ratings on the
5D-ASC score “ego dissolution” (item 71 of the questionnaire), as pre-
viously reported (Carhart-Harris et al., 2016b). No other signiﬁcant
associations have been reported. Correlations with the plasma levels of
LSD were calculated using the individual plasma levels of LSD mea-
sured at 2 h after administration – directly before the MRI scan, as the
resting state sequence was the ﬁrst sequence in our protocol. Calcula-
tions were performed using SPSS version 23.00 (IBM).
2.10. Relationship with blood pressure, heart rate, and body temperature
It has already been shown that LSD increases physiological para-
meters (PP) such as blood pressure, heart rate and body temperature
(Schmid et al., 2015; Dolder et al., 2017b). As all of these factors might
bias FC results (Khalili-Mahani et al., 2013), a second correlation ana-
lysis was performed in order to assess possible associations. This ana-
lysis was conducted in the same manner as described above, i.e. al-
terations in physiological parameters (ΔPP=PPLSD− PPPlacebo) at 2 h
after administration were correlated (Pearson's r) with individual FC
measures (ΔPE=PELSD− PEPlacebo) of signiﬁcant FC results. This was
done for systolic blood pressure (ΔSBP), diastolic blood pressure
(ΔDBP), heart rate (ΔHR), and body temperature (ΔBT) and signiﬁcant
FC results of all three analysis (within network FC, between network FC
and seed-to-voxel analysis). Results were corrected for multiple com-
parisons (FDR).
Please see online Supplement for additional methods detail.
3. Results
3.1. Identiﬁcation of resting state networks
Of the 20 components of the ICA analysis, eight were classiﬁed as
mainly reﬂecting artifacts. The remaining 12 components were cross-
correlated to the ten templates provided by Smith et al. (2009). All ten
templates were identiﬁed in our data set and were labeled accordingly
(see Supplemental Fig. 2): Visual networks 1–3 (r= 0.87, r= 0.35,
r= 0.64), DMN (r= 0.82), cerebellum (r= 0.62), sensorimotor net-
work (r= 0.79), auditory network (r= 0.70), executive control net-
work (r= 0.55), and frontoparietal networks 1–2 (r= 0.57, r= 0.53).
Two networks corresponded to RSNs not included in the ten templates.
3.2. Within-network connectivity
The drug and placebo conditions were compared between all ten
networks. Signiﬁcantly decreased coactivation under the drug condi-
tion relative to placebo was found in visual networks 1 and 3 (covering
almost all parts of these networks), in large parts of the sensorimotor
network, in the medial-posterior part of the DMN, and a small cluster in
the right inferior frontal gyrus of the auditory network. Results are
shown in Fig. 1 and online Supplemental Table 2. We observed in-
creased coactivation relative to placebo in small clusters in areas that
were not covered by the networks in the analysis of the visual networks
2 (right superior parietal lobe) and 3 (precuneus), and of the fronto-
parietal network 1 (left inferior frontal gyrus; see Supplemental Fig. 3).
3.3. Between-network connectivity
Widespread increases in between-network FC were observed under
LSD compared with placebo. All investigated networks were aﬀected to
some extent; this was most pronounced for the visual network 1, the
cerebellum and the executive network (see Fig. 2). No decreases in FC
were observed.
3.4. Seed-to-voxel analysis
Seed-to-voxel analysis using all ten networks as seeds also reﬂected
profound increases in FC (see Supplemental Fig. 4). Visual inspection of
the results indicated that certain regions were repeatedly involved
(especially occipital and subcortical areas). This ﬁnding was further
investigated by merging all results shown in Supplemental Fig. 4 to
illustrate overlaps (see Fig. 3A). Overlaps of more than four components
were observed in the cerebellum, occipital regions (lingual gyrus, in-
tracalcarine cortex, precuneus), frontal regions (frontal medial cortex,
right frontal pole, anterior cingulate cortex), and subcortical structures
(bilateral thalamus, putamen, pallidum, and caudate). The largest
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overlaps (> 6 components) were observed in the bilateral thalamus and
caudate. Detailed projections of RSNs on these structures are shown in
Fig. 4.
3.5. Analysis of hub structures
As several of these regions are known hubs and are thus thought to
serve integration and large-scale interaction between brain regions, we
suspected that these structures might be critically involved in drug-in-
duced changes in large-scale FC. To investigate this possibility, the
main eﬀect of all networks was assessed by simultaneously including all
ten networks as seeds and calculating a weighted contrast (reﬂecting
the common eﬀect of these seeds on voxels covering the whole brain;
cluster threshold p < 0.05, FDR, cluster-forming threshold p < 0.001
uncorrected). Common eﬀects were observed in a few regions (see
Fig. 3B and Supplemental Table 3), particularly subcortical structures
(thalamus, putamen, caudate, cerebellum), and precuneus and frontal
areas (anterior cingulate cortex, frontal pole, middle frontal gyrus).
3.6. Relationship with subjective drug eﬀects and plasma levels
Decreased FC within the auditory network correlated signiﬁcantly
with the 5D-ASC major dimensions “visionary restructuralization”
(r=−0.53, p= 0.02), and “auditory alterations” (r=−0.49,
p=0.03). However, these associations did not remain signiﬁcant when
adjusted for multiple comparisons (FDR). No other signiﬁcant correla-
tions between within-network FC and subjective eﬀects were observed
(see Supplemental Table 4). No signiﬁcant associations between FC
measures and plasma levels were observed (see Supplemental Table 4).
No signiﬁcant correlation was observed between DMN integrity and
subjective ratings on the item “ego dissolution” (r= 0.06, p=0.81).
3.7. Relationship with blood pressure, heart rate, and body temperature
No signiﬁcant correlations (p < 0.05) between physiological
parameters and FC measures were observed for within-network con-
nectivity and for seed-to-voxel analysis. For between-network con-
nectivity, there were some signiﬁcant correlations between ΔSBP,
ΔDBP, ΔBT and FC measures (ΔSBP and visual network 1-visual net-
work 3: r= 0.64, p < 0.01; ΔSBP and sensorimotor network – execu-
tive network: r=−0.54, p=0.01; ΔDBP and visual network 1 – visual
network 3: r= 0.52, p=0.01; ΔBT and visual network 2 – executive
network: r= 0.46, p=0.04). However, none of these results remained
signiﬁcant after correction for multiple comparisons (FDR). Even more
importantly, there was no evidence for a systematic (non-signiﬁcant)
relationship between one of the physiological parameters and altera-
tions in FC induced by LSD. All results are presented in Supplemental
Fig. 5. Additionally, physiological parameters under the placebo and
the drug condition are given in Supplemental Table 5.
4. Discussion
This study investigated the acute eﬀects of LSD on network con-
nectivity in healthy subjects. We found that acute LSD administration
decreased FC within the DMN, the auditory and sensorimotor networks
and visual networks 1 and 3. Between-network FC was widely increased;
Fig. 1. Between-condition diﬀerences in within-network functional connectivity. Only decreased connectivity (shown in blue-green) was observed for the contrast LSD > placebo.
Results are overlayed on the corresponding resting state networks obtained in our analysis (yellow). Images are thresholded at p < 0.005 (two tailed), FWE (threshold free cluster
enhancement). X, Y, and Z values indicate MNI coordinates. Right is the right side of the brain. (For interpretation of the references to color in this ﬁgure legend, the reader is referred to
the online version of this chapter.)
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all RSNs were aﬀected to some degree, particularly the cerebellum and
the executive network. Seed-to-voxel analysis indicated that increased
FC of RSNs on a whole-brain level consistently involved hub structures
(speciﬁcally thalamus and striatum). Below, we discuss our ﬁndings in
the context of previous observations obtained after the administration
of LSD (Carhart-Harris et al., 2016b; Tagliazucchi et al., 2016) and the
related hallucinogenic drug psilocybin (Carhart-Harris et al., 2013;
Roseman et al., 2014). Like LSD, psilocybin exerts its eﬀects mainly
through agonism at the 5-HT2A-receptor (Vollenweider et al., 1998;
Preller et al., 2017).
Our results on alterations in within-network connectivity closely
resemble those previously reported in LSD (Carhart-Harris et al.,
2016b), where decreases in coactivation within the DMN, the sensor-
imotor network and the visual networks 1 and 3 were reported. Ad-
ditionally, Carhart-Harris et al. reported decreases in the right fronto-
parietal network and the parietal cortex network and found no
alterations within the auditory network. We did not investigate the
parietal network in our study and the frontoparietal network was not
aﬀected in our analysis. The functional relevance of decreased within-
network FC to subjective drug eﬀects is largely unknown. No signiﬁcant
associations were described in previous studies with psilocybin
(Carhart-Harris et al., 2013; Roseman et al., 2014). For LSD, decreased
coactivation within the DMN was signiﬁcantly associated with feelings
of “ego dissolution” (Carhart-Harris et al., 2016b), a ﬁnding that could
not be replicated in our study – although ego dissolution varied
markedly across subjects and correlated with exposure to LSD (Liechti
et al., 2016). Within this context, it should be noted, that very similar
alterations in within-network connectivity were reported after the ad-
ministration of sertraline, a selective serotonin reuptake inhibitor
(Klaassens et al., 2015). Klaassens et al. studied the eﬀects of sertraline
on connectivity using the same RSN templates and similar methods of
analysis; they pinpointed exactly the same networks as in our study
(DMN, visual networks 1–3, sensorimotor and auditory network). These
ﬁndings also overlapped with regions identiﬁed in a previous study
with LSD (Carhart-Harris et al., 2016b). These eﬀects of sertraline, a
drug causing no major subjective eﬀects, call into question the speci-
ﬁcity of these alterations and their signiﬁcance for subjective drug ef-
fects. It is possible that they represent an epiphenomen of unspeciﬁc
serotonergic stimulation.
Between-network connectivity was examined in two previous stu-
dies after administration of either psilocybin (Carhart-Harris et al.,
2013; Roseman et al., 2014) or LSD (Carhart-Harris et al., 2016b). With
psilocybin, FC between an anterior DMN and nine other RSNs was in-
vestigated (Carhart-Harris et al., 2013); FC was increased between the
anterior DMN and dorsal attention, salience, right frontoparietal, and
auditory networks. Broader analyses of FC between several networks
indicated widespread increases in between-network FC under psilo-
cybin (Roseman et al., 2014) and – to a considerably lesser extent –
under LSD (Carhart-Harris et al., 2016b). Fig. 5 shows a comparison of
these ﬁndings of these studies with our results. In general, there was no
good accordance within the results of previous studies (Roseman et al.,
2014; Carhart-Harris et al., 2016b) or between those studies and our
ﬁndings. It does not seem very likely that these widely divergent
ﬁndings simply reﬂect diﬀerent eﬀects of psilocybin and LSD, as their
mechanism of action at the 5HT2A-receptor is very similar (Rickli et al.,
2016), as are probably the subjective eﬀects (Hollister and Hartman,
1962; Hollister and Sjoberg, 1964). Furthermore, our results diﬀered
considerably from those recently reported for LSD (Carhart-Harris et al.,
2016b). These diﬀerences might be due to signiﬁcant diﬀerences in
movement between conditions present in those studies and diﬀerent
methods of analysis, diﬀerences in regions covered by RSNs, or the
slightly larger sample size in our study. Moreover, routes of adminis-
tration (i.v. and oral administration) or the previous experiences of
participants with hallucinogenic drugs might have aﬀected the results.
Seed-to-voxel analyses indicated increased FC between RSNs and
several structures known as hubs (precuneus, anterior cingulate cortex,
striatum and thalamus). Hubs are thought to be of importance for
overall brain functioning by serving integration and large-scale inter-
action (van den Heuvel and Sporns, 2013; Bell and Shine, 2016). Using
functional connectivity density analysis, a previous study has already
reported signiﬁcantly increased global connectivity in several regions
after the administration of LSD and psilocybin, including the precuneus
and thalamus (Tagliazucchi et al., 2016). In the present study, it was
found that FC between the great majority of RSNs and striatum and
thalamus was increased after administration of LSD, compared with
Fig. 2. Correlation matrix illustrating widespread increased functional connectivity be-
tween resting state networks under the drug condition compared to placebo. The colorbar
indicates the t value, asterisks indicate signiﬁcant diﬀerences (p < 0.05, FDR, two
tailed). (For interpretation of the references to color in this ﬁgure legend, the reader is
referred to the online version of this chapter.)
Fig. 3. A: Results of seed-to-voxel analysis shown in Supplemental Fig. 4 combined in one
map. The color bar indicates the number of converging components. B: Main eﬀect of all
ten resting state networks in seed-to-voxel analysis (cluster threshold p < 0.05, FDR, two
tailed, cluster-forming threshold p < 0.001 uncorrected). Right is right side of the brain.
(For interpretation of the references to color in this ﬁgure legend, the reader is referred to
the online version of this chapter.)
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placebo. Both structures (striatum and thalamus) show widespread
structural connections to other brain regions (Jones, 2007; Parent and
Hazrati, 1995) and are part of the so called “rich club”, a set of highly
connected regions that are densely connected among themselves (van
den Heuvel and Sporns, 2011; Schmidt et al., 2016). The striatum
(comprised of caudate and putamen) is the main input structure of the
basal ganglia (Parent and Hazrati, 1995) and is connected to numerous
cortical regions via loops (Alexander et al., 1986) which pass through
the basal ganglia, to the thalamus and back to the cortex (cortico-
striato-thalamo-cortical loops). We have already investigated thala-
mocortical FC after administration of LSD in the same sample in more
detail (Müller et al., 2017). Among others, we found increased global
FC of striato-thalamic structures after LSD compared with placebo. This
could indicate that these regions are speciﬁcally inﬂuenced by LSD. It is
interesting to note that the thalamic and striatal projections for the
DMN, sensorimotor and frontoparietal networks observed in this study
were relatively similar to the topography of cortical projections on
these regions observed in several fMRI studies (Hale et al., 2015; Yuan
et al., 2016; Zhang et al., 2008; Zhang et al., 2010; Choi et al., 2012).
However, the visual networks 1–3 and the auditory network did not
follow this pattern, and occupied large portions of these subcortical
structures.
The importance of hub lesions in brain disorders has recently been
emphasized (Crossley et al., 2014). Alterations in thalamocortical FC
have long been suspected to be involved in the pathophysiology of
schizophrenia (Lisman et al., 2010; Pinault, 2011; Ferrarelli and
Tononi, 2011) and have been one of the few neuroimaging ﬁndings that
have been repeatedly replicated in the search of the neural correlates of
schizophrenia. Several studies indicated that FC between thalamus and
frontal regions is decreased while FC between thalamus and sensor-
imotor areas is increased (for an overview see (Giraldo-Chica and
Woodward, 2017)). It is remarkable that data-driven FC analysis in one
of the biggest samples to date has identiﬁed alterations in thalamo-
cortical FC as an outstanding characteristic of schizophrenia (Cheng
et al., 2015). The ﬁndings reported by those authors very closely re-
semble those found in our data set (see Fig. 3) and, additionally to the
thalamus, also comprise the pallidum and striatum. These observations
might indicate that not only the thalamus but also the whole cortico-
striato-thalamo-cortical circuitry is involved in altered brain func-
tioning in schizophrenia as well as in altered states of consciousness
induced by LSD, as has already suspected (Geyer and Vollenweider,
2008; Andreasen, 1999). Maybe these similarities could also explain
why hallucinogenic drugs can induce psychotic episodes in vulnerable
subjects (Vardy and Kay, 1983), rather than in the general population
(Johansen and Krebs, 2015) as they might act on a system that is al-
ready impaired in patients in at-risk states of psychosis (Anticevic et al.,
2015).
On the other side, a recent model proposed that altered hub con-
nectivity induced by hallucinogens might also explain their therapeutic
eﬀects (Nichols et al., 2016). Various studies have indicated that these
Fig. 4. Functional projections of resting state networks on striatal (left) and thalamic (right) structures. Only increases in FC were observed (cluster threshold p < 0.005, FDR, two tailed,
cluster-forming threshold p < 0.001). Right is right side of the brain.
Fig. 5. Comparison of the eﬀects of hallucinogenic drugs on between-network con-
nectivity obtained by another group (Carhart-Harris et al., 2016b; Roseman et al., 2014)
and our results. All results on networks identiﬁed in the present study were included.
Asterisks indicate signiﬁcant diﬀerences between drug and placebo condition (green:
Roseman et al., 2014; blue: Carhart-Harris et al., 2016b; red: present study). Black in-
dicates networks which were not investigated. Roseman et al. reported separate results
for two representation of the DMN, which were combined in this presentation. (For in-
terpretation of the references to color in this ﬁgure legend, the reader is referred to the
online version of this chapter.)
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substances might have beneﬁcial eﬀects in distinct mental disorders like
depression, anxiety, and addiction. It is an interesting question, how a
single mechanism of action can exert positive eﬀects in heterogeneous
diseases. Nichols et al. hypothesize that this link can be found in altered
hub connectivity induced by these drugs. According to this model,
pathological connectivity patterns associated with diverse mental dis-
eases are acutely altered through destabilization of hub functions with
subsequent changes in FC between various brain regions. These events
somehow give rise to the development of new connectivity patterns
which are stabilized after the acute eﬀects have subsided, possibly
through anti-inﬂammatory eﬀects (Nichols et al., 2016).
This study is limited by a relatively small sample size and the use of
a moderately high dose of LSD. Functional MRI is only an indirect
measure for neuronal activity and relies on neurovascular coupling.
LSD might alter neurovascular coupling, as already reported for the
related serotonergic drug psilocin (Spain et al., 2015). This might result
in biased FC results (Liu, 2013). LSD-induced alterations in physiolo-
gical parameters such as heart rate and blood pressure might also aﬀect
FC (Khalili-Mahani et al., 2013). We found no evidence for a systematic
relationship between alterations in physiological parameters and
functional connectivity in our data set. However, these measures were
taken only at one time point before the fMRI scan and nuisance re-
gression of continuously recorded parameters might have been prefer-
able.
Furthermore, the fMRI environment might have negatively inﬂu-
enced subjective drug eﬀects (Studerus et al., 2012). Although hallu-
cinogenic drugs seem to mimic some symptoms present in schizo-
phrenia (Gouzoulis-Mayfrank et al., 1998; Carhart-Harris et al., 2016a;
Liechti, 2017), there are presumably also important diﬀerences. Firstly,
negative symptoms as commonly seen in schizophrenia are probably
not present to this extent with hallucinogens, which mainly induce ef-
fects similar to positive symptoms (De Gregorio et al., 2016). Secondly,
there are also important diﬀerences among the positive symptoms, such
as the predominance of visual hallucinations in hallucinogens com-
pared to mainly auditory hallucinations in schizophrenia. ICA results
are inﬂuenced by the prespeciﬁed dimensionality (i.e. the prespeciﬁed
number of components) (Ray et al., 2013). However, we restricted ICA
to 20 components in order to allow direct comparison with established
templates by Smith et al. (Smith et al., 2009) and with results from
previous studies using LSD (Carhart-Harris et al., 2016b) and psilocybin
(Carhart-Harris et al., 2013).
5. Conclusion
In the search of neuronal correlates of altered states of conscious-
ness induced by LSD, we could replicate previous ﬁndings describing
decreased functional connectivity within RSNs. However, the relevance
and speciﬁcity of these alterations for LSD-induced eﬀects are ques-
tioned by lacking associations with subjective drug eﬀects as well as
very similar observations obtained after the administration of a ser-
otonin reuptake inhibitor. In line with previous results, we found
widely increased between-network connectivity. Closer inspection,
however, indicated very little consistencies in altered FC between
speciﬁc RSNs in our sample and previous ﬁndings in LSD and psilo-
cybin. Therefore, it seems doubtful that one of these measures is a re-
liable and characteristic neuronal correlate of hallucinogenic drug ef-
fects. Importantly, our results indicated increased connectivity between
networks and subcortical and cortical hub structures. This ﬁnding is in
line with previous observations in psychopathological states, especially
in psychosis. According to a recent model, altered hub connectivity
might also explain improvements observed in various mental diseases
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